Unverricht-Lundborg Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Unverricht-Lundborg Syndrome

What is the definition of Unverricht-Lundborg Syndrome?

Progressive myoclonic epilepsy type 1 (also called Unverricht-Lundborg disease or ULD) is a rare inherited form of epilepsy. Early development is normal in affected individuals. Signs and symptoms of the disorder typically begin between 6 and 15 years of age.

What are the causes of Unverricht-Lundborg Syndrome?

Variants (also called mutations) in the CSTB gene cause progressive myoclonic epilepsy type 1. The CSTB gene provides instructions for making a protein called cystatin B. This protein reduces the activity of enzymes called cathepsins. Cathepsins help break down certain proteins in the lysosomes, which are compartments in the cell that digest and recycle different types of molecules. While the specific function of cystatin B is unclear, it may help protect the cells' proteins from cathepsins that leak out of the lysosomes.

How prevalent is Unverricht-Lundborg Syndrome?

Progressive myoclonus epilepsy is a rare group of conditions.  Progressive myoclonic epilepsy type 1 is believed to be the most common form of this type of epilepsy, but its worldwide prevalence is unknown. The condition is more common in the North African countries of Tunisia, Algeria, and Morocco.  Progressive myoclonic epilepsy type 1 occurs most frequently in Finland, where approximately 2 in 100,000 people are affected.

Is Unverricht-Lundborg Syndrome an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell must have a variant to cause the disorder. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

Who are the top Unverricht-Lundborg Syndrome Local Doctors?
Advanced in Unverricht-Lundborg Syndrome
Advanced in Unverricht-Lundborg Syndrome
Referral may be required

Northwell Health Physician Partners Neuroscience Institute At Great Neck

611 Northern Boulevard, Suite 150, 
Great Neck, NY 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Sean Hwang is a Neurologist practicing medicine in Great Neck, New York. Dr. Hwang is rated as an Advanced provider by MediFind in the treatment of Unverricht-Lundborg Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Memory Loss, Epilepsy, and Gastrostomy. Dr. Hwang is board certified in American Board Of Psychiatry/Neurology-Epilepsy, American Board Of Psychiatry & Neurology-Neurophysiology, and American Board Of Psychiatry/Neurology-Neurology. Dr. Hwang is currently accepting new patients.

Elite in Unverricht-Lundborg Syndrome
Elite in Unverricht-Lundborg Syndrome
Referral may be required
Box 100, KYS, 
Kuopio, FI 

Reetta Kalviainen practices practicing medicine in Kuopio, Finland. Kalviainen is rated as an Elite expert by MediFind in the treatment of Unverricht-Lundborg Syndrome. They are also highly rated in 14 other conditions, according to our data. Their clinical expertise encompasses Unverricht-Lundborg Syndrome, Dentatorubral-Pallidoluysian Atrophy, Lafora Disease, and Myoclonic Epilepsy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Unverricht-Lundborg Syndrome
Elite in Unverricht-Lundborg Syndrome
Referral may be required
P.O. Box 100, FI-70029 KYS, 
Kuopio, FI 

Ritva Vanninen practices practicing medicine in Kuopio, Finland. Vanninen is rated as an Elite expert by MediFind in the treatment of Unverricht-Lundborg Syndrome. They are also highly rated in 13 other conditions, according to our data. Their clinical expertise encompasses Unverricht-Lundborg Syndrome, Dentatorubral-Pallidoluysian Atrophy, Lafora Disease, Thrombectomy, and Mastectomy.

What are the latest Unverricht-Lundborg Syndrome Clinical Trials?
Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)

Summary: The Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1) is focused on gathering longitudinal clinical data as well as biological samples (blood and/or urine) from male and female patients, of all ages, who have a molecular diagnosis of EPM1or CSTB-null-related disease. Currently, there are no therapies that halt disease progression in any CSTB-related diseases, high...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: March 27, 2024
Published By: National Institutes of Health